Biochemistry, BSc - University of California Los Angeles, 2009


Lisa joined the USC family in 2009 and discovered her interest in cancer immunotherapy while rotating in W. Martin Kast’s lab. The focus of her research is to better prostate cancer immunotherapies with an augmenter ligand, LIGHT, found to attract naïve T cells into tumor microenvironments, manipulate regulatory T cells and induce antigen-specific CD8+ T cells. Her interest includes studying tumor microenvironments and suppressive T cells that dampen the efficacy of cancer vaccines.

NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.